A case of cardiogenic syncope in a drug-dependent patient;Un caso di sincope di origine cardiogena in paziente farmaco-dipendente

Italian Heart Journal Supplement

Volumn 5, Issue 10, 2004, Pages 824-828

  Portale, Grazia ^a   Straccamore, Federica ^a   Mazzone, Marinella ^a   Mirabella, Cristina ^a   Carbone, Luigi ^a   Pignataro, Giulia ^a   Testa, Americo ^a   Covino, Marcello ^a   Silveri, Nicolò Gentiloni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Arrhythmias; Cocaine; Long QT syndrome; Syncope

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; COCAINE DEPENDENCE; ELECTROCARDIOGRAPHY; EMERGENCY; HEART RATE; HUMAN; LONG QT SYNDROME; MALE; MONITORING; SYNCOPE; TORSADE DES POINTES;

ADULT; COCAINE-RELATED DISORDERS; ELECTROCARDIOGRAPHY; EMERGENCIES; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MONITORING, PHYSIOLOGIC; SYNCOPE; TORSADES DE POINTES;

EID: 16644401201     PISSN: 15903796     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tzivoni D, Keren A, Stern S. Torsades de pointes versus polymorphous ventricular tachycardia. Am J Cardiol 1983; 52: 639-40.
2. Horowitz LN, Greenspan AM, Spielman SR, et al. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation 1981; 63: 1120-8.
3. Marban E. Cardiac channelopathies. Nature 2002; 415: 213-8.
4. Tan HL, Hou CJ, Lauer MR, et al. Electrophysiological mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995; 122: 701-14.
5. Shimizu W. Genotype-specific clinical manifestation in long QT syndrome. Expert Rev Cardiovasc Ther 2003; 1: 401-9.
6. Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med 1998; 49: 263-4.
7. El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol 2003; 18: 6-13.
8. Walker BD, Krahn AD, Klein GJ, Skanes AC, Yee R. Drug induced QT prolongation: lessons from congenital and acquired long QT syndromes. Curr Drug Target Cardiovasc Haematol Disord 2003; 3: 327-35. (Pubitemid 37540863)
9. Roden D. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 10: 1013-22.
10. Schutte D, Obel W. Dangerous and life-threatening drugs - practical lessons from the long QT syndrome. Cadiovasc J S Afr 2002; 13: 54-61. (Pubitemid 34742290)
11. Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 2003; 10: 452-7.
12. Khan IA, Moe TW, Arvind JB, et al. Torsades de pointes: a case with multiple variables. Am J Emerg Med 1999; 17: 80-5.
13. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348: 1866-74.
14. Schrem S, Belsky P, Schwartzman D, Slater W. Cocaine-induced torsades de pointes in a patient with the idiopathic long QT syndrome. Am Heart J 1990; 120: 980-4.
15. Kloner RA, Hale S, Alker K, Rezkalla S. The effect of acute and chronic cocaine use on the heart. Circulation 1992; 85: 407-19.
16. Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ. Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations. J Clin Pharmacol 1994; 34: 902-11.
17. Kimura S, Basset AL, Xi H, Myerburg RJ. Early afterdepolarizations and triggered activity induced by cocaine. A possible mechanism of cocaine arrhythmogenesis. Circulation 1992; 85: 2227-35.
18. Clarkson CW, Xu YQ, Chang C, Follmer CH. Analysis of the ionic basis for cocaine's biphasic effect on action potential duration in guinea-pig ventricular myocytes. J Mol Cell Cardiol 1996; 28: 667-78.
19. Perera R, Kraebber A, Schwartz MJ. Prolonged QT interval and cocaine use. J Electrocardiol 1997; 30: 337-9.
20. kr potassium channel. Cell 1995; 81: 229-307.
21. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995; 269: 92-5.
22. ks cardiac potassium current. Nature 1996; 384: 78-80.
23. ks potassium channel. Nature 1996; 384: 80-3.
24. Zhang S, Rajamani S, Chen Y, et al. Cocaine blocks HERG, but not KvLQT1+minK, potassium channels. Mol Pharmacol 2001; 59: 1069-76. (Pubitemid 32381586)
25. Erzouki HK, Baum I, Goldberg SR, Schindler CW. Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats. J Cardiovasc Pharmacol 1993; 22: 557-63. (Pubitemid 23286751)
26. William K, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med 1997; 15: 321-9.
27. Bauman JL, DiDomenico RJ. Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death. J Cardiovasc Pharmacol Ther 2002; 7: 195-202.
28. Riaz K, McCullough PA. Fatal case of delayed repolarization due to cocaine abuse and global ischemia. Rev Cardiovasc Med 2003; 4: 47-53. (Pubitemid 36949835)
29. Gamouras GA, Monir G, Plunkitt K, Gursoy S, Dreifus LS. Cocaine abuse: repolarization abnormalities and ventricular arrhythmias. Am J Med Sci 2000; 320: 9-12. (Pubitemid 30471284)